|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023688,
umls-concept:C0025266,
umls-concept:C0040300,
umls-concept:C0155626,
umls-concept:C0205217,
umls-concept:C0229671,
umls-concept:C0243077,
umls-concept:C0439231,
umls-concept:C0441889,
umls-concept:C0521447,
umls-concept:C0538161,
umls-concept:C0597357,
umls-concept:C1521761
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-7-9
|
|
pubmed:abstractText |
Osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) are critical regulators of bone remodeling and RANKL/RANK signaling could also play an important role in the remodeling process of several tissues, such as myocardium. Therefore, we investigated whether the serum concentrations of OPG and RANKL correlate with the serum levels of metalloproteinase-1 (MMP-1), MMP-9 and tissue inhibitors of MMP-1 (TIMP-1), which are known regulators of myocardial healing in acute myocardial infarction (AMI) patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1434-6621
|
|
pubmed:author |
pubmed-author:HalapasAntoniosA,
pubmed-author:KaravidasApostolosA,
pubmed-author:KatopodisHarrisH,
pubmed-author:KorresDimitriosD,
pubmed-author:KoutsilierisMichaelM,
pubmed-author:LembessisPeterP,
pubmed-author:PapadopoulosKostantinosK,
pubmed-author:StavropoulouAnastasiaA,
pubmed-author:TheocharisStamatiosS,
pubmed-author:XiromeritisCostasC,
pubmed-author:ZacharoulisAchilleasA,
pubmed-author:ZacharoulisApostolosA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
510-6
|
|
pubmed:meshHeading |
pubmed-meshheading:18298349-Acute Disease,
pubmed-meshheading:18298349-Aged,
pubmed-meshheading:18298349-Blood Chemical Analysis,
pubmed-meshheading:18298349-Case-Control Studies,
pubmed-meshheading:18298349-Echocardiography,
pubmed-meshheading:18298349-Gene Expression Regulation,
pubmed-meshheading:18298349-Humans,
pubmed-meshheading:18298349-Male,
pubmed-meshheading:18298349-Matrix Metalloproteinase 1,
pubmed-meshheading:18298349-Middle Aged,
pubmed-meshheading:18298349-Myocardial Infarction,
pubmed-meshheading:18298349-Osteoprotegerin,
pubmed-meshheading:18298349-Receptor Activator of Nuclear Factor-kappa B,
pubmed-meshheading:18298349-Time Factors,
pubmed-meshheading:18298349-Tissue Inhibitor of Metalloproteinase-1
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Serum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction.
|
|
pubmed:affiliation |
Department of Experimental Physiology, Medical School, University of Athens, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article
|
